Thank you @sharmaruchi29 and @Kapilbharti123 for your mentorship throughout the years!! This would not have been possible without you! I'm very excited to start this new adventure 😁 Many thanks to @NatEyeInstitute and @_BrightFocus for supporting my career!

I'm excited to announce Kapil Bharti's selection as Scientific Director for the @NatEyeInstitute. Kapil is a superb basic/translational scientist - he'll lead >20 labs, 6 core facilities, & 300 staff in our Intramural Research Program. https://t.co/18dqdEKSC8 @KapilkBharti123

@DavideOrtolan91 provides a protocol he developed to perform single cell analysis of human RPE/choroid. His previous work in PNAS used this protocol and made a groundbreaking discovery of five RPE sub populations.

Online in @STARProtocols: #Differentiation #protocol to generate pure #retinal pigment epithelium cells from induced pluripotent #stemcells, from Dr. Kapil Bharti's lab @Kapilbharti123 @sharmaruchi29 @DavideOrtolan91 @NatEyeInstitute: https://t.co/kns0CqpzS7

Check out this #differentiation #protocol to generate pure #retinal pigment epithelium cells from induced pluripotent #stemcells, from Dr. Kapil Bharti's lab @Kapilbharti123 @sharmaruchi29 @DavideOrtolan91 @NatEyeInstitute: https://t.co/p0E4DWOdvh

(1/2) Clinical trial surgery at @NatEyeInstitute led by @Kapilbharti123: #RPE patch developed from autologous #StemCells successfully implanted! 15 years' work: innovation in retinal biology, iPSCs, cell manufacturing, materials science, retinal surgery https://t.co/2mg8hgVMvZ

News: First U.S. patient receives autologous stem cell therapy to treat dry AMD

@NIH I cannot thank the team enough. Over 10 years of efforts went into preparation for this day. I am honored to work such a dedicated team who made this happen. @NatEyeInstitute @NIH_CommonFund @CellDynamics @ARVOinfo @ISSCR @ISCTglobal @sharmaruchi29 @DavideOrtolan91

Congratulations to @NatEyeInstitute Intramural researcher Mitra Farnoodian Tedrick (from @BhartiLab) for receiving the Knights Templar Eye Foundation grant to help develop potential therapies for #Stargardt disease! https://t.co/S7cS0SVR1i

Mapping #retina pigment epithelial cells – greater understanding of cell types affected in #eye diseases. Video and research by @DavideOrtolan91 et al @Kapilbharti123 @NIH in @PNASNews. Read more on https://t.co/ENxSZry3CJ with @MRC_LMS and @EnricoStennito

@DavideOrtolan91, @SharmaRuchi29, @Kapilbharti123 and co map out #retinal pigment epithelium using #ArtificialIntelligence, which could lead to more precise therapies for degenerative eye diseases. https://t.co/dR28IFv4YC

New work reveals that the retinal pigment epithelium (RPE) is made up of 5 distinct cell populations, each in a specific location. This explains location-dependent susceptibility to eye diseases. @Kapilbharti123 @sharmaruchi29 @DavideOrtolan91 https://t.co/CCJy8FVW0w

Creating a map of RPE cells subpopulations with differential retinal diseases sensitivity. Findings will help in developing precise cell & #GeneTherapies. Innovative work by @davideortolan91 @sharmaruchi29 @kapilbharti123

News: Retinal cell map could advance precise therapies for blinding diseases

Here's the link to the paper:

Finally out in @PNASNews!! Thank you to @sharmaruchi29 and @Kapilbharti123 that made this work possible and all the people that contributed to the work! @NatEyeInstitute

#NEIfunded researchers @Kapilbharti123 and @DavideOrtolan91 developed a map of RPE cells -- identifying subpopulations with relevance to disease vulnerability. A big advance for gene and stem therapies for degenerative diseases. #regenerativemedicine https://t.co/pttt5X9I8l

And thanks to @NatEyeInstitute too for the support!!

Hey #arvo2022! Come check out my poster (F0408) on human RPE heterogeneity. We defined 5 RPE subpopulations with different sensitivity to retinal diseases. Thanks to @_BrightFocus and all the colleagues in @Kapilbharti123 lab for contributing to the work!!

#ARVO2022 don't miss the latest #NEIfunded iPSC-RPE studies looking at CFH risk variants and disease propensity.